← Back to Search

Cardiac surgery for Heart Failure

Waitlist Available
Led By Richard E Pratley, MD
Research Sponsored by AdventHealth Translational Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Screening 3 weeks
Treatment Varies
Follow Up restricted to the time around surgical procedure
Awards & highlights

Study Summary

This trial will help researchers understand changes in metabolism in patients that develop heart failure.


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~restricted to the time around surgical procedure
This trial's timeline: 3 weeks for screening, Varies for treatment, and restricted to the time around surgical procedure for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Analyses of collected tissues

Trial Design

1Treatment groups
Experimental Treatment
Group I: Cardiac surgeryExperimental Treatment1 Intervention
Subjects will be recruited by a coordinator through electronic medical record (EMR) searches to identify those undergoing left ventricle assist device (LVAD) implantation and explantation, heart transplant, valve replacement or repair, endomyocardial biopsy during catheterization, and arterial bypass surgery. Prior to the procedure, potential subjects will be informed about the clinical study and if interested, they will be consented.

Find a Location

Who is running the clinical trial?

Florida Hospital Cardiovascular InstituteUNKNOWN
AdventHealth Translational Research InstituteLead Sponsor
48 Previous Clinical Trials
20,126 Total Patients Enrolled
Translational Research Institute for Metabolism and Diabetes, FloridaLead Sponsor
40 Previous Clinical Trials
3,542 Total Patients Enrolled

Media Library

Cardiac surgery Clinical Trial Eligibility Overview. Trial Name: NCT03032627 — N/A
Heart Failure Research Study Groups: Cardiac surgery
Heart Failure Clinical Trial 2023: Cardiac surgery Highlights & Side Effects. Trial Name: NCT03032627 — N/A
Cardiac surgery 2023 Treatment Timeline for Medical Study. Trial Name: NCT03032627 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies in this clinical experiment that a participant can fill?

"The records hosted on clinicaltrials.gov disclose that this experiment is not presently enrolling patients; the trial was initially posted on March 20th 2017, and last updated April 12th 2022. Though it's currently in stasis, there are 700 other trials actively seeking participants right now."

Answered by AI

Does the study encompass participants aged eighty-five and older?

"This research is accepting volunteers aged between 19 and 89."

Answered by AI

What criteria must be met in order to qualify for this clinical experiment?

"This clinical trial, which is looking to recruit up to 55 candidates, seeks participants with heart failure that are between the ages of 19 and 89."

Answered by AI
~7 spots leftby Apr 2025